The draft regulation concerns azoxystrobin, atrazine, chlormequat, cyprodinil, dithiocarbamatse, fludioxonil, fluroxypyr, indoxacarb, mandipropamid, potassium tri-iodide, spirotetramat, tetraconazole and thiram.
Der Verordnungsentwurf betrifft Azoxystrobin, Atrazin, Chlormequat, Cyprodinil, Dithiocarbamaten, Fludioxonil, Fluroxypyr, Indoxacarb, Mandipropamid, Kaliumtriiodid, Spirotetramat, Tetraconazol und Thiram.